Best Stock Report – Penny Stock Newsletter Tracking

****<<>>****

Free Hot Penny Stocks (FHPS) brings our Investing Community the Newest SYMBOL of the Month Cancer Therapeutics Inc. ticker CTHP.

CTHP is our newest alerted company from FHPS. CTHP is a great Bulletin Board company that is poised for growth at a substantial rate over the next few months . This company is part of the Healthcare sector but more specifically the Medical Laboratories & Research Industry. They are located in South Jordan, UT where they focus on disruptive cancer treatments and nanotechnology.

CTHP will soon soar above the competing companies in its sector. Below you will find a concise summary of CTHP business description. The current price is a bargain and provides potential to post significant profits in the near future. Buy low and sell high are key measures for any investor. Cancer Therapeutics is no different.

In 2008 it is estimated that cancer claimed the lives of 294,120 men and 271,530 women US according to American Cancer Society. Second only to the number of deaths attributed to heart disease. CTHP research gives hope to ever American that has cancer or will have cancer. The opportunity to be part of this company at such a discounted cost can not be passed up.

Nano also owns all right to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability. Nano Therapies have sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia). Nano also owns all rights to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.

Four drugs have been identified for accelerated market delivery and early revenue: Methotrexate, Cytarabine, Fludarabine and Daunorubicin. Cerimide-based drugs and a newly discovered Amplified Photon Emission Therapy (APET) also comprise part of the product portfolio, but will require longer clinical trials to get to market!

Please visit CTHP website below for more information and subscribe to their corporate news letter:

www.cancer-therapeutics.com

CTHP is biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. The end result will be therapies, treatments and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTI seeks partners to co-develop drugs in various stages of the pipeline.

Metatron Inc. (MRNJ.PK)

Yesterday we alerted on Metatron Inc. (MRNJ.PK) and today it posted a return of 16.67%. It was up $.05 for the day. It has its letter of intent to acquire Just Data Inc. and the deal is expected to close in early September. This was the first day for MRNJ so do not hesitate to add it to your watch list. FHPS predicts big things from this company in the next week. So keep an eye for an email soon.

Pigs get Fat, Hogs get Slaughtered!

FHPS always recommends that each investors conducts there own due diligence on each alerted company prior to investing.

FHPS Staff

_____________________________________________________________________________

The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Release of Liability: Through use of this website viewing or using you agree to hold FreeHotPennyStocks which is owned and operated by FreeHotPennyStocks.com and its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.

FreeHotPennyStocks is written and published by FreeHotPennyStocks.com employees. Readers are advised that this analysis report is issued solely for informational purposes. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. FreeHotPennyStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice.

All information on featured companies is provided by the companies profiled, or is available from public sources and FreeHotPennyStocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. FreeHotPennyStocks, nor any of its affiliates are not registered investment advisors or a broker dealers. FreeHotPennyStocks has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. FreeHotPennyStocks has also been advised that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. FreeHotPennyStocks makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through FreeHotPennyStocks. FreeHotPennyStocks owners may or may not hold positions in the companies that are profiled. Investing in securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

For a full disclaimer, visit http://www.freehotpennystocks.com/disclaimer.html

For your further information, FreeHotPennyStocks expects to be compensated fifty thousand dollars for a one month investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Yasheng Eco Trade Corp.

For your further information, FreeHotPennyStocks has agreed to be compensated twenty-five thousand dollars for a one month investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Applied DNA Sciences Inc. Freehotpennystock has agreed to be paid another fifty thousand dollars for a two months of continuous service.

For your further information, FreeHotPennyStocks has agreed to be compensated fifty thousand dollars for a one month investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Copsync Inc.

For your further information, FreeHotPennyStocks has agreed to be compensated twenty-five thousand dollars for a one month investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Metatron Inc.

For your further information, FreeHotPennyStocks has agreed to be compensated fifteen thousand dollars for a one week investor awareness campaign by a third party in compensation for the consulting, profiling and/or marketing of Cancer Therapeutics Inc..

Third Party Web Sites and Information FreeHotPennyStocks and newsletter may provide hyperlinks to third party websites or access to third party content. FreeHotPennyStocks.com does not control, endorse, or guarantee content found in such sites. You agree that FreeHotPennyStocks is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that FreeHotPennyStocks. shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.